Breast Cancer: Oral SERDs in ER+ breast cancer. Episode 2 - treatment selection and beyond

episode

COR2ED Medical Education not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

The Freedom of Love_ Why Living Apart Together is the New Gold Standard (Part 2) 3 min · 24 Sep 2026 · Conspiracy Theories Exploring The Unseen

The Freedom of Love_ Why LAT is the New Standard (Part 1) 2 min · 24 Sep 2026 · Conspiracy Theories Exploring The Unseen

The Dating Paradox_ Why 2026 Singles Are Choosing The Sidelines (Part 2) 2 min · 24 Sep 2026 · Conspiracy Theories Exploring The Unseen

The Dating Paradox_ Why 2026 Singles are Opting Out, Part 1 2 min · 24 Sep 2026 · Conspiracy Theories Exploring The Unseen

The Intimacy Paradox_ Decoding the Dating Recession (Part 2) 2 min · 24 Sep 2026 · Conspiracy Theories Exploring The Unseen

The Intimacy Paradox_ Why We Are More Connected Yet More Alone (Part 1) 2 min · 24 Sep 2026 · Conspiracy Theories Exploring The Unseen

Report any issue

Source

Recorded26 Jul 2023

Publisherfeeds.castos.com ↗

Handlerec:14025971

Show notes

COR2ED Medical Education: In this podcast, the experts deep-dive into two patient case studies of ER+/HER2- metastatic breast cancer, discussing the intricacies of treatment selection and sequencing to maximise outcomes, current data, and what to consider when adjusting dosage or switching treatments. Dr. Rena Callahan an Associate Clinical Professor of Hematology Oncology at University of California, Los Angeles David Geffen School of Medicine and Dr. Shaheenah Dawood, a consultant medical oncologist and professor of oncology at Mediclinic City Hospital, United Arab Emirates, Dubai discuss oral SERDs, a novel therapy for ER+/HER2- advanced or metastatic breast cancer.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in